Skip to content

Clinical trials

Recruiting Observational Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Observational Status: Recruiting Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20093
20111
20131
20141
20161
20182
20192
20201
20214
202210
20237
202412
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Aarhus University Hospital2
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2
Children's Oncology Group2
Columbia University2
Resonance, Inc.2
UNC Lineberger Comprehensive Cancer Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Alliance for Clinical Trials in Oncology1
Bundang CHA Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma59
Leukemia, Myeloid, Acute11
Leukemia9
Lymphoma8
Hematologic Neoplasms6
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Non-Hodgkin6
Hodgkin Disease5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Lymphoma, Large B-Cell, Diffuse5

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.